Navigating Ischemic and Bleeding Risks in High Bleeding Risk Patients Undergoing Coronary Intervention
A standardized whole-process management framework for HBR patients undergoing PCI is constructed, incorporating 2024–2026 cutting-edge evidence on ultra-short DAPT stratification strategies, gene-guided antiplatelet therapy adjustment, and novel factor XI (FXI) inhibitor antithrombotic regimens, further refining the in...